Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
The lung infection with Pseudomonas aeruginosa is regarded as one of the major causes of health decline in patients with cystic fibrosis (CF). The CF host response to the persistent bacterial antigen load in the endobronchiolar lumen is characterized by a pronounced humoral response, local production of cytokines, influx of neutrophils into the lung and a protease-protease inhibitor imbalance predominantly sustained by released neutrophil elastase. CF is an autosomal recessive disease, and we could demonstrate for our local patient population that the age-dependent risk to become chronically colonized with P. aeruginosa can be differentiated by the disease-causing CFTR mutation genotype. The age-specific colonisation rates were significantly lower in pancreas sufficient than in pancreas insufficient patients. P. aeruginosa is occasionally detected in throat swabs already in infancy or early childhood in most patients although there is a lapse of several years amenable to preventive measures such as vaccination until onset of persistent colonization. The epidemiology of the infection with P. aeruginosa was investigated by quantitative macrorestriction fragment pattern analysis. The distribution and frequency of clones found in CF patients match that found in other clinical and environmental aquatic habitats, but the over-representation of specific clones at a CF clinic indicates a significant impact of nosocomial transmission for the prevalence of P. aeruginosa-positive patients at a particular center. Most patients remain colonized with the initially acquired P. aeruginosa clone. According to direct sputum analysis the majority of patients is carrying a single clonal variant at a concentration of 10(7)-10(9) CFU. Co-colonization with other species or other clones is infrequent. Independent of the underlying genotype, the CF lung habitat triggers a uniform, genetically fixed conversion of bacterial phenotype. Most CFP, aeruginosa strains become non-motile, mucoid, LPS-, pyocin- and phage-deficient, secrete less virulence determinants and shift the production of cytokines evoked in neutrophils. On the other hand, other properties such as antimicrobial susceptibility or adherence to bronchial mucins remain highly variable reflecting the capacity of P. aeruginosa to adapt to ongoing changes in the CF lung habitat.
Tümmler
B
B
Klinische Forschergruppe Molekulare Pathologie der Mukoviszidose, Zentrum Biochemie, Hannover, Germany.
Bosshammer
J
J
Breitenstein
S
S
Brockhausen
I
I
Gudowius
P
P
Herrmann
C
C
Herrmann
S
S
Heuer
T
T
Kubesch
P
P
Mekus
F
F
Römling
U
U
Schmidt
K D
KD
Spangenberg
C
C
Walter
S
S
D003550:Cystic Fibrosis / Q000150:complications / Q000276:immunology / Q000382:microbiology*; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics; D004198:Disease Susceptibility; D006801:Humans; D008168:Lung / Q000382:microbiology; D008171:Lung Diseases / Q000382:microbiology*; D010641:Phenotype; D011552:Pseudomonas Infections / Q000453:epidemiology* / Q000209:etiology / Q000276:immunology; D011550:Pseudomonas aeruginosa / Q000235:genetics* / Q000302:isolation & purification
C505032:CFTR protein, human; D019005:Cystic Fibrosis Transmembrane Conductance Regulator